Altogether, further studies on the role of Sp1 and its IFN-inducible inhibitors, i.e., TRIM22 and IFI16, as well as subtype-specific differences in the establishment and maintenance of latent HIV-1 infections, seem highly warranted. The gene discussed is IFNA1; the disease is HIV-1 infection.